Shanghai Medicilon

About:

Medicilon has been recognized as one of the top drug discovery contract research organizations (CRO) in China

Website: http://www.medicilon.com

Twitter/X: Medicilon

Top Investors: Fortune Venture Capital, Tianjin Venture Capital, Renhe Capital

Description:

Medicilon is an integrated contract research organization (CRO), providing comprehensive one-stop new drug R&D services for pharmaceutical enterprises and scientific research institutions around the world. Based on key links of drug R&D, we focus on the demand for innovation and the development of the global pharmaceutical industry. With our experience in serving domestic and foreign biomedical industries, we have built an integrated technical platform covering key technologies in drug discovery, pharmaceutical research, and preclinical research, in a bid to provide comprehensive preclinical new drug R&D for the global biomedical industry.